TickerHumSide-by-side comparison
Bristol-Myers Squibb vs Medtronic
As of Sep 28, 2026, P/E is 14.0x for Bristol-Myers Squibb vs 21.8x for Medtronic; P/S is 2.6x for Bristol-Myers Squibb vs 3.0x for Medtronic; revenue growth is 3.1% for Bristol-Myers Squibb vs 9.8% for Medtronic; net margin is 18.9% for Bristol-Myers Squibb vs 13.9% for Medtronic.
What stands out
- Bristol-Myers Squibb is cheaper on earnings: 14.0x P/E vs 21.8x for Medtronic.
- Medtronic carries less debt relative to equity: 0.51 vs 1.89 for Bristol-Myers Squibb.
- Bristol-Myers Squibb's shares did better over the past year: +44.0% vs -5.6% for Medtronic.
- Bristol-Myers Squibb scores higher on TickerHum's ratings: 71/100 vs 61/100 for Medtronic.
Key metrics
| Metric | BMY | MDT |
|---|---|---|
| Price | $63.58 | $88.69 |
| Market cap | $129.87B | $113.45B |
| P/E | 14.0x (#1) | 21.8x (#2) |
| P/S | 2.6x (#1) | 3.0x (#2) |
| Revenue growth | 3.1% (#2) | 9.8% (#1) |
| Operating margin | — | 18.1% (#1) |
| Net margin | 18.9% (#1) | 13.9% (#2) |
| Debt / equity | 1.89 (#2) | 0.51 (#1) |
| 1-year return | +44.0% (#1) | -5.6% (#2) |
| Research score | 71/100 (#1) | 61/100 (#2) |
Higher is better for growth, margins, one-year return and overall score; lower is better for valuation and debt ratios. Ties share a rank and missing values are excluded.
Company research
- Bristol-Myers Squibb Company (BMY) — Drug Manufacturers—General
- Medtronic plc (MDT) — Medical Devices